BPC-157
BPC-157, short for Body Protection Compound-157, is a synthetic peptide derived from a naturally occurring protective protein sequence...
Explore Guide →Evidence-informed educational resources covering peptide mechanisms, metabolic signaling, storage practices, research pathways and investigational compound comparisons.
Beginner-friendly educational resources covering peptide mechanisms, storage, preparation and research terminology.
BPC-157, short for Body Protection Compound-157, is a synthetic peptide derived from a naturally occurring protective protein sequence...
Explore Guide →Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist widely studied for its...
Explore Guide →Semaglutide is a long-acting GLP-1 receptor agonist widely studied for its role in appetite regulation, glucose metabolism, and...
Explore Guide →Retatrutide is an investigational peptide designed to target multiple metabolic pathways involved in energy balance, appetite regulation, and...
Explore Guide →Not sure where to start? Explore peptide categories based on your research goals, including weight management, recovery, growth hormone research, longevity and performance.
Explore Peptide Categories →Explore educational resources and research compounds designed for laboratory and investigational use.
View Peptide Collection →BPC-157 and TB-500 are among the most popular peptides studied in tissue repair and recovery research. Although they are frequently mentioned together, the two compounds differ in origin, structure, and research focus....
Explore Guide →Retatrutide and Tirzepatide are next-generation metabolic research peptides that target multiple hormonal pathways involved in glucose regulation, energy balance, and body weight control. While Tirzepatide acts as a dual GIP and GLP-1...
Explore Guide →Semaglutide and Tirzepatide are two of the most widely researched incretin-based peptides for weight management and metabolic health. While Semaglutide acts as a GLP-1 receptor agonist, Tirzepatide targets both GIP and GLP-1...
Explore Guide →Common questions about peptide research, mechanisms, and educational resources.
Research peptides are short chains of amino acids studied for their interaction with biological pathways and receptors.
GLP-1 and GIP are incretin hormones involved in metabolic signaling and glucose regulation pathways.
Peptides are commonly researched for receptor activity, metabolic effects, and signaling interactions.
Storage practices may vary depending on compound stability, preparation, and research conditions.
An agonist is a compound that activates a receptor to trigger a biological response or signaling pathway.
Retatrutide is researched for activity across GLP-1, GIP, and glucagon receptor pathways.